Profile
Wendy Chang currently works at Zentalis Pharmaceuticals, Inc., as Chief People Officer from 2024.
Ms. Chang also formerly worked at IDbyDNA, Inc., as Head-People & Culture, Harpoon Therapeutics, Inc., as Senior Vice President-Human Resources from 2022 to 2023, and Gilead Sciences, Inc., as Vice President-Human Resources from 2003 to 2020.
Ms. Chang received her undergraduate degree from the University of California, Riverside.
Wendy Chang active positions
| Companies | Position | Start |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Human Resources Officer | 2024-12-11 |
Former positions of Wendy Chang
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Human Resources Officer | 2019-12-31 |
IDbyDNA, Inc.
IDbyDNA, Inc. BiotechnologyHealth Technology Develops technologies that will enable nucleic acid based identification testing services | Human Resources Officer | - |
| HARPOON THERAPEUTICS, INC. | Human Resources Officer | - |
Training of Wendy Chang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
University of California, Riverside
University of California, Riverside Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
IDbyDNA, Inc.
IDbyDNA, Inc. BiotechnologyHealth Technology Develops technologies that will enable nucleic acid based identification testing services | Health Technology |
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
- Stock Market
- Insiders
- Wendy Chang
















